| Cardiovascular
(CV) diseases are the leading cause of death and disability
in India. The WHO 2000 report indicates that the number
of CV deaths in India per year is 23 million, with 52%
of these deaths being due to coronary artery disease
(CAD). It is estimated that by the year 2020, there
would be a 111% increase in CV death due to CAD.3
Serdia Pharmaceuticals is committed
to the field of cardiology by manufacturing high quality
research products that will help the doctors to reduce
the burden of CV diseases in India. In addition, we
offer a number of medical services, which could be of
great value to the doctors and patients. Please click
on any of the icons below for more information. |
top